Hella Kohlhof
Immunic Therapeutics AG, Germany
Biography
Hella Kohlhof is the CSO and Co-founder of Immunic AG. She studied biology in Aachen, Gothenborg (Sweden) and Munich and received her Doctorate in Biology from the LMU in Munich (Germany). During her Ph.D. and PostDoc at the at the Helmholtz Centre in Munich, she worked in the field of immunology and oncology. In 2008 she joined 4SC AG as group leader for translational pharmacology. From 2011 on, Hella was responsible for the management and development of one epigenetic clinical stage small molecule inhibitor and from 2015 on, as Director Development Projects, responsible for the complete development portfolio of 4SC AG.